{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:55:14Z","timestamp":1788897314986,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Monoclonal gammopathies, such as Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM), are conditions marked by the overproduction of specific monoclonal proteins. Patients with these conditions are known to have a higher risk of fractures compared to the general population, yet there are no established guidelines for assessing or managing their skeletal health. The Trabecular Bone Score (TBS), which can be calculated from DXA images of the lumbar spine, provides additional insights into bone microarchitecture. Methods: This study aimed to determine whether TBS can serve as a supplementary tool in assessing bone loss in MGUS and SMM patients. Conducted from 2020 to 2023, the study involved 148 participants\u201474 diagnosed with a myeloma precursor state and 74 healthy controls\u2014who underwent simultaneous DXA and TBS measurements. Results: The results indicated a weak positive correlation (R = 0.405) between DXA and TBS T-scores, suggesting that other factors may influence the measurements. When analyzed separately, the correlations remained weak for both MGUS (R = 0.250) and SMM (R = 0.485). Interestingly, discrepancies were noted in T-score classifications; for instance, a patient classified as normal via DXA could be deemed osteopenic or osteoporotic with TBS. Conclusions: Overall, the findings suggest that incorporating TBS alongside DXA can enhance the accuracy of bone density assessments, facilitating earlier diagnosis and treatment initiation for osteoporosis in asymptomatic patients with monoclonal gammopathies.<\/jats:p>","DOI":"10.3390\/jcm13216461","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:39:07Z","timestamp":1730104747000},"page":"6461","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trabecular Bone Score as a Complementary Tool for the Assessment of Bone Mineral Density in Patients with Asymptomatic Monoclonal Gammopathies"],"prefix":"10.3390","volume":"13","author":[{"given":"Styliani","family":"Drakoulidou","sequence":"first","affiliation":[{"name":"Department of Radiology, Alexandra Hospital, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6328-9783","authenticated-orcid":false,"given":"Ioannis","family":"Ntanasis-Stathopoulos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Kyritsi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Koutoulidis","sequence":"additional","affiliation":[{"name":"First Department of Radiology, School of Medicine, Areteion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-171X","authenticated-orcid":false,"given":"Panagiotis","family":"Malandrakis","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kanellias","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-5832","authenticated-orcid":false,"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-3254","authenticated-orcid":false,"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"},{"name":"Department of Medicine, Korea University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gavriatopoulou","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-639X","authenticated-orcid":false,"given":"Athanasios","family":"Chalazonitis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Alexandra Hospital, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-1422","authenticated-orcid":false,"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kyle, R.A. (2001). An Evaluation of Patients with Monoclonal Gammopathies, Humana Press.","DOI":"10.1007\/978-1-59259-228-9_18"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hillengass, J., Moehler, T., and Hundemer, M. (2011). Monoclonal Gammopathy and Smoldering Multiple Myeloma: Diagnosis, Staging, Prognosis, Management, Springer.","DOI":"10.1007\/978-3-540-85772-3_6"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.hoc.2014.06.005","article-title":"Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma","volume":"28","author":"Kyle","year":"2014","journal-title":"Hematol.\/Oncol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5045\/br.2022.2022035","article-title":"Diagnosis and management of monoclonal gammopathy of clinical significance","volume":"57","author":"Cho","year":"2022","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.blre.2007.01.002","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"21","author":"Rajkumar","year":"2007","journal-title":"Blood Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"ITC177","DOI":"10.7326\/AITC202212200","article-title":"Monoclonal Gammopathy of Undetermined Significance","volume":"175","author":"Gonsalves","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic review","volume":"85","author":"Wadhera","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ejh.13633","article-title":"Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study","volume":"107","author":"Aspelund","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"115394","DOI":"10.1016\/j.bone.2020.115394","article-title":"Use of trabecular bone score for risk stratification of patients with monoclonal gammopathy of undetermined significance","volume":"137","author":"Sfeir","year":"2020","journal-title":"Bone"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: A population-based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","article-title":"Fracture risk in patients with monoclonal gammopathy of undetermined significance","volume":"135","author":"Gregersen","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000162282","article-title":"Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures","volume":"120","author":"Golombick","year":"2008","journal-title":"Acta Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations with monoclonal gammopathy of undetermined significance: A population-based study of 17,398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00198-007-0525-7","article-title":"Secondary contributors to bone loss in osteoporosis related hip fractures","volume":"19","author":"Edwards","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11914-013-0154-3","article-title":"Osteoporosis and cancer","volume":"11","author":"Drake","year":"2013","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance","volume":"134","author":"Pepe","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.38376.401701.8F","article-title":"Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: Retrospective, cross sectional study","volume":"330","author":"Abrahamsen","year":"2005","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2018-11-852459","article-title":"Myeloma bone disease: From biology findings to treatment approaches","volume":"133","author":"Terpos","year":"2019","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","article-title":"Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: Results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11657-022-01168-9","article-title":"Trabecular bone score in the hip: A new method to examine hip bone microarchitecture-a feasibility study","volume":"17","author":"Haeri","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jocd.2012.05.001","article-title":"Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: Effects of resolution and noise","volume":"16","author":"Winzenrieth","year":"2013","journal-title":"J. Clin. Densitom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","article-title":"Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitectan experimental study on human cadaver vertebrae","volume":"14","author":"Hans","year":"2011","journal-title":"Clin. Densitom."},{"key":"ref_24","first-page":"S85","article-title":"Relationship between Trabecular Bone Score (TBS), Bone Mass, and Microarchitecture in Human Vertebrae: An ex vivo Study","volume":"23","author":"Roux","year":"2012","journal-title":"Osteoporosis. Int."},{"key":"ref_25","first-page":"4","article-title":"Indice TBS: La microarchitecture par DXA","volume":"302","author":"Hans","year":"2009","journal-title":"Abstr. Rhumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"International Myeloma Working Group (2003). Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br. J. Haematol., 121, 749\u2013757.","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"ref_28","unstructured":"World Health Organisation (1994). Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis, WHO."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Greenacre, M., and Blasius, J. (2006). Multiple Correspondence Analysis and Related Methods, Chapman and Hall\/CRC. [1st ed.].","DOI":"10.1201\/9781420011319"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Shevroja, E., Lamy, O., Kohlmeier, L., Koromani, F., Rivadeneira, F., and Hans, D. (2017). Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-Energy X-Ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice, Elsevier.","DOI":"10.1016\/j.jocd.2017.06.019"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.2176","article-title":"Trabecular bone score: A noninvasive analytical method based upon the DXA image","volume":"29","author":"Silva","year":"2014","journal-title":"J. Bone Miner."},{"key":"ref_32","first-page":"115491","article-title":"Trabecular Bone Score (TBS) as a new complementary approach for fracture risk assessment in clinical practice","volume":"137","author":"Harvey","year":"2020","journal-title":"Bone"},{"key":"ref_33","unstructured":"International Osteoporosis Foundation (2023). Important Update on the Use of Trabecular Bone Score (TBS) in Clinical Practice, International Osteoporosis Foundation."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-014-0280-4","article-title":"Utility of the trabecular bone score (TBS) in secondary osteoporosis","volume":"47","author":"Ulivieri","year":"2014","journal-title":"Endocrine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.afos.2018.05.003","article-title":"Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma","volume":"4","author":"Lee","year":"2018","journal-title":"Osteoporos. Sarcopenia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jbmr.2387","article-title":"Unveiling Skeletal Fragility in Patients Diagnosed with MGUS: No Longer a Condition of Undetermined Significance?","volume":"29","author":"Drake","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-021-04400-7","article-title":"Risk factors for monoclonal gammopathy of undetermined significance: A systematic review","volume":"100","author":"Ulbricht","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/bloodadvances.2023010843","article-title":"Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population","volume":"8","author":"Lee","year":"2024","journal-title":"Blood Adv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","article-title":"Obesity and multiple myeloma: Emerging mechanisms and perspectives","volume":"92","author":"Tentolouris","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17256","article-title":"Controversies in the use of new bone-modifying therapies in multiple myeloma","volume":"193","author":"Terpos","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/1078-0432.CCR-08-0666","article-title":"Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss","volume":"14","author":"Berenson","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ajh.27206","article-title":"Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA","volume":"99","author":"Terpos","year":"2024","journal-title":"Am. J. Hematol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6461\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:22:19Z","timestamp":1760113339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":45,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216461"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216461","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}